Active Ingredient(s):Venetoclax FDA Approved: * April 11, 2016 Pharm Company: *ABBVIE INC Category:Cancer
Venetoclax, sold under the brand names Venclexta and Venclyxto, is a medication used to treat adults with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or acute myeloid leukemia (AML).
The most common side effects are low levels of neutrophils (a type of white blood cell), diarrhea, nausea, anemia (low red blood cell counts), nose and throat infection and tiredness.
Venetoclax attaches to a protein called Bcl-2.&...
* May have multiple approval dates, manufacturers, or labelers.